All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports
KCE Reports 306 (2019) A healthy lifestyle remains the most effective way of avoiding cardiovascular diseases and their consequences. Yet since 2002, the annual number of people who use cholesterol-lowering drugs from the statin family increased from 400,000 to 1,500,000. Currently, 25% of the population aged 40 and above take these drugs. Despite decreases in price due to the fact that all statins now exist in generic form, their total cost still stands at 160 million euros annually.
KCE Reports 305 (2019) For several years, KCE has undertaken background work to improve the quality of care to patients with cancer, together with the Cancer Registry Foundation and College of Oncology. Over time, this project should lead to a true system of quality monitoring, including clinical recommendations, quality indicators and a hospital benchmarking and feedback dynamic. This year, efforts have concentrated on head and neck cancers.